Hyliion Holdings Corp. HYLN
3.15 USD +0.06 (+1.94%)
At closeNov 4, 2026, 8:37 AM EST
3.24 +0.09 +2.90%
Pre-market · Nov 4, 8:37 AM ET
3.00 Day range 3.36
1.56 52-week range 8.49
- YTD
- +71.20%
- 1 year
- +50.72%
Analyst view
Consensus: buy
Buy
Price target (mean) 7.00 +122.2% upside
Now 3.15
- Target (low)
- 5.00
- Target (mean)
- 7.00
- Target (high)
- 9.00
Ratings (0m) 3 2 buy · 1 hold · 0 sell
- Strong buy1
- Buy1
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 2
- 2 months ago 2
- 3 months ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.07 | -0.07 – -0.07 | 0.00 | 0.0% | 2.40M | +58.4% | 1 |
| Next quarter | -0.07 | -0.07 – -0.07 | -0.08 | +12.5% | 2.50M | +229.4% | 1 |
| Current year | -0.28 | -0.28 – -0.28 | -0.3289 | +14.9% | 11.65M | +235.3% | 1 |
| Next year | -0.305 | -0.34 – -0.27 | -0.28 | -8.9% | 38.40M | +229.6% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 10, 2026 | Needham | Initiated | — | Buy |
| Oct 21, 2025 | Johnson Rice | Initiated | — | Buy |
| Aug 13, 2024 | Northland Capital Markets | Maintained | Market Perform | Market Perform |
| Oct 12, 2023 | Northland Capital Markets | Downgrade | Outperform | Market Perform |
| Oct 12, 2023 | Cantor Fitzgerald | Downgrade | Neutral | Underweight |
| Aug 14, 2023 | Goldman Sachs | Maintained | Sell | Sell |
| Aug 10, 2023 | Cantor Fitzgerald | Maintained | Neutral | Neutral |
| May 11, 2023 | Cantor Fitzgerald | Maintained | Neutral | Neutral |
| Apr 13, 2023 | Goldman Sachs | Maintained | — | Sell |
| Apr 12, 2023 | Goldman Sachs | Maintained | — | Sell |
| Mar 7, 2023 | Goldman Sachs | Maintained | — | Sell |
| Mar 6, 2023 | Goldman Sachs | Maintained | — | Sell |
| Mar 2, 2023 | UBS | Maintained | — | Neutral |
| Nov 22, 2022 | Northland Capital Markets | Initiated | — | Outperform |
| Nov 10, 2022 | Goldman Sachs | Maintained | — | Sell |
| Aug 11, 2022 | Cantor Fitzgerald | Downgrade | Overweight | Neutral |
| Jun 21, 2022 | JP Morgan | Downgrade | Neutral | Underweight |
| May 11, 2022 | Goldman Sachs | Maintained | — | Sell |
| Mar 10, 2022 | Barclays | Maintained | — | Equal-Weight |
| Mar 2, 2022 | UBS | Upgrade | Sell | Neutral |
| Nov 11, 2021 | Barclays | Downgrade | Overweight | Equal-Weight |
| Oct 11, 2021 | UBS | Downgrade | Neutral | Sell |
| Jul 6, 2021 | Cantor Fitzgerald | Initiated | — | Overweight |
| Mar 18, 2021 | UBS | Initiated | — | Neutral |
| Feb 3, 2021 | Goldman Sachs | Downgrade | Neutral | Sell |
| Oct 28, 2020 | JP Morgan | Initiated | — | Neutral |
| Oct 15, 2020 | Goldman Sachs | Initiated | — | Neutral |